Tech Company Financing Transactions
ProLacta BioSciences Funding Round
On 9/20/2006, ProLacta BioSciences announced $5 million in Series B funding from Arcturus Capital, Draper Richards and Funk Ventures Capital Partners.
Transaction Overview
Company Name
Announced On
9/20/2006
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series B
Investors
Proceeds Purpose
The funding will be used for clinical studies and working capital.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1800 Highland Ave.
Duarte, CA 91010
USA
Duarte, CA 91010
USA
Phone
Undisclosed
Website
Email Address
Overview
Prolacta Biosciences, headquartered in Monrovia, California is a life sciences company that provides specialty formulations of human milk for the immunological and nutritional needs of premature and critically ill infants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Elster
Chief Medical Officer
David Rechtman
VP - Operations
Joseph Fournell
VP - Operations
Mark Hannon
VP - R & D
Martin Lee
VP - Regulatory Affairs
Scott Eaker
VP - Sales
Alan Kofsky
Browse more venture capital transactions:
Prev: 9/19/2006: Solaria venture capital transaction
Next: 9/20/2006: Ideal Image Development venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs